Effect of basic fibroblast growth factor-saporin mitotoxin on breast cancer cell lines in vitro

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Fibroblast growth factor receptors (FGFRs) are prevalent on breast cancer cells.
• Targeted delivery of cytotoxic agents to cancer cells is a key therapeutic strategy.
• Fibroblast growth factor 2 (FGF2) is implicated in cancer cell proliferation.

Purpose of the Study:

• To evaluate the potential of fibroblast growth factor receptors as targets for delivering a cytotoxic conjugate.
• To assess the efficacy of a fibroblast growth factor 2-saporin conjugate in inhibiting breast cancer cell growth.

Main Methods:

• A mitotoxin conjugate of FGF2 and saporin was synthesized.
• Binding affinity of the conjugate to FGF2 receptors was measured using I-125-FGF2 displacement assays.
• Cytotoxicity and growth inhibition assays were performed on multiple breast cancer cell lines.

Main Results:

• The FGF2-saporin conjugate demonstrated displacement of I-125-FGF2 binding, albeit with reduced affinity.
• The conjugate effectively inhibited cell growth in 4 out of 5 tested breast cancer cell lines.
• Significant cytotoxicity was observed in at least 2 of the cell lines; activity was independent of FGF2 responsiveness and not seen with free saporin.

Conclusions:

• Fibroblast growth factor receptors are potential targets for delivering cytotoxic agents like the FGF2-saporin conjugate to breast cancer cells.
• The conjugate shows promise for both experimental studies of receptor function and potential clinical applications in eliminating cancer cells.
• This targeted approach offers a novel strategy for cancer therapy, distinct from the effects of the cytotoxic payload alone.